filmov
tv
Dr. Petrylak on the Role of PSA Screening in Prostate Cancer
Показать описание
Daniel P. Petrylak, MD, discusses the role of prostate-specific antigen (PSA) screening in prostate cancer.
OncLive
cancer
oncology
Рекомендации по теме
0:01:18
Dr. Petrylak on the Role of PSA Screening in Prostate Cancer
0:00:39
Daniel Petrylak, MD, on the current role of CTC tumor cell components via liquid biopsy PC treatment
0:00:25
Daniel P. Petrylak, MD, on the role of DNA repair gene mutations in metastatic urothelial carcinoma
0:00:56
Meet Oncologist Daniel Petrylak, MD
0:13:33
ASCO® 2024 Insights: Dr. Daniel Petrylak
0:05:28
ASCO® 2024 Insights: Dr. Daniel Petrylak on ARV-766
0:01:01
Dr. Petrylak on Novel Immunotherapy Research in Bladder Cancer
0:00:37
Dr. Petrylak on FDA Approval of Nivolumab in Bladder Cancer
0:03:03
Daniel Petrylak, MD, discusses the role of checkpoint inhibition therapy in urothelial carcinoma
0:00:57
Dr. Petrylak on Immunotherapy in Bladder Cancer
0:00:56
Daniel Petrylak, MD shares his thoughts on the CARD study presented at ASCO GU 2020
0:02:51
FDA approves new bladder cancer drug | Dr. Daniel Petrylak
0:00:50
PSMA ADC for prostate cancer
0:00:56
Dr. Petrylak on Ongoing Investigations of Checkpoint Inhibition in Bladder Cancer
0:01:47
Dr. Petrylak on Sequencing of Targeted Agents in Bladder Cancer
0:01:05
Dr. Petrylak on Combinations with Pembrolizumab in Urothelial Carcinoma
0:01:29
Dr. Daniel Petrylak on the IMvigor Study of Atezolizumab in Advanced Bladder Cancer
0:10:33
Daniel P. Petrylak - Clinical Trials in MIBC and NMIBC
0:02:01
Dr. Petrylak Shares Gratitude for Being Named a 2017 Giant of Cancer Care in GU Cancer
0:00:38
Dr. Petrylak on FDA Approval of Pembrolizumab in Bladder Cancer
0:01:06
Dr. Daniel Petrylak on Early Trials for a New Urothelial Bladder Cancer Treatment
0:00:57
Dr. Petrylak on the KEYNOTE-045 Trial for Urothelial Carcinoma
0:01:36
Daniel P. Petrylak, MD invites you to the 15th Annual NYGU™ Conference on March 11-12
0:01:41
Dr. Petrylak on Immunotherapy for Second-line Treatment in Bladder Cancer
0:00:39
0:00:25
0:00:56
0:13:33
0:05:28
0:01:01
0:00:37
0:03:03
0:00:57
0:00:56
0:02:51
0:00:50
0:00:56
0:01:47
0:01:05
0:01:29
0:10:33
0:02:01
0:00:38
0:01:06
0:00:57
0:01:36
0:01:41